Aggressive Brain Cancer: Geneva Hospital Team Offers Hope
Okay, here’s a thorough HTML article based on the provided sources, adhering to all your specifications. It’s a considerable piece, aiming for SEO value and user engagement. I’ve focused on providing a clear, informative, and well-structured article.
“`html
personalized Cell Therapy Offers New Hope for Aggressive Brain Cancer
Table of Contents
Recent breakthroughs in immunotherapy are showing promising results in the fight against glioblastoma, one of the most challenging forms of brain cancer. researchers are developing tailor-made cells designed to target and destroy tumor cells, offering a potential new treatment option for patients with limited alternatives.
Understanding Glioblastoma: The Challenge
glioblastoma (GBM) is a grade IV astrocytoma, the most aggressive type of cancer that begins in the brain. It’s characterized by rapid growth and spread, and unfortunately, treatment options are limited.Standard treatment typically involves surgery,followed by radiation therapy and chemotherapy with temozolomide. Though, recurrence is common, and the median survival rate remains around 15-18 months.
The challenge with treating glioblastoma lies in several factors:
- Blood-Brain Barrier: This protective barrier makes it difficult for drugs to reach the tumor.
- Tumor Heterogeneity: Glioblastoma tumors are highly variable, with different cells exhibiting different characteristics.
- Aggressive Growth: The rapid growth rate allows the tumor to quickly develop resistance to treatment.
The Science Behind Personalized Cell Therapy
The innovative approach being developed focuses on harnessing the power of the patient’s own immune system. Here’s a breakdown of the process:
- T-Cell Collection: T-cells, a type of white blood cell crucial for immune response, are collected from the patient’s blood.
- Genetic Modification: These T-cells are genetically engineered to express a chimeric antigen receptor (CAR). this CAR is specifically designed to recognize a protein found on the surface of glioblastoma cells.
- Cell Expansion: The modified CAR-T cells are grown in the lab to increase their numbers.